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Abstract
Objectives: We investigated the relationship between insulin resistance reflected by homeostasis model assessment (HOMA-
IR) index and serum HbA1c levels of  obese children.
Material and Methods: This study included 70 obese and 60 normal weight healthy children between the ages of  3 and 15. 
Anthropometric measures and biochemical tests (fasting glucose, fasting insulin, HbA1c) were performed on all subjects. 
Plasma glucose levels were measured by the glucose oxidase method. Plasma insulin concentrations were measured by 
radioimmunoassay (RIA). HOMA-IR index was used to estimate insulin resistance. A cut-off  HOMA-IR level of  ≥2.5 
was accepted. The HbA1c analysis was performed using high-pressure liquid chromatography. The statistical analysis 
was performed using SPSS 5. Student’s unpaired t-test and the Mann–Whitney U test were used to determine statistical 
significance.
Results: Gender distribution did not reveal significant difference among the obese (F: 48.6%, M: 51.4%) and the non-obese 
(F: 46.7%, M: 53.3%) groups. The mean age value was significantly higher in the obese group (10.09± 3.09) (p>0.005) than 
the non-obese group (8.31±3.14) (p<0.05).  The mean value of  body mass index (BMI) was 25.55±4.3 in the obese group 
and 16.63±2.3 in the non-obese group. The mean HOMA-IR values of  obese group (2.84±1.77) was significantly higher 
than the non-obese group (1.50±0.95) (p<0.005). Insulin resistance was significantly higher in the obese group. Subjects with 
HOMA-IR ≥2.5 levels in the obese group had significantly higher HbA1c values than those with HOMA-IR <2.5 levels.
Conclusions: High HbA1c levels in obese children can be used as a screening tool to detect insulin sensitivity and resistance 
at an early stage.
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Introduction
The earlier onset of  obesity in children may 
cause a longer period of  insulin resistance, which may 
explain the concomitant earlier onset of  impaired 
glucose tolerance in children and adolescents. In this 
study, we determined the validity of  HbA1c screening to 
identify obese children at high risk for insulin resistance 
and diabetes at an early stage. We aimed to evaluate the 
association of  HOMA-IR and HbA1c levels 
in obese and non-obese children to assess insulin 
resistance, a condition that can cause diabetes mellitus 
and metabolic syndrome in adults.
Material and Methods
The subjects included 70 obese and 60 non-obese 
children (130 children in total) between 3 and 15 years 
old, who were taken to our clinic by the symptomatology 
of  upper respiratory tract infection, between January 
and December of  2012. Known genetic causes of  
obesity and chronic illnesses were excluded after having 
underwent consultations by pediatric endocrinology 
department. Obesity was defined as a body mass index 
(BMI) ≥95th percentile for age and sex, according to 
the growth references for Turkish children.
Parents were required to sign a written consent 
to allow their children to participate in this study. All 
children reported by parents to be suffering from 
metabolic, endocrine, liver, or kidney disorders were 
excluded. The study was approved by Local Ethic 
Committee.
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Height was measured to the last millimeter 
using a portable stadiometer, and weight was recorded 
to the nearest 0.11 kg using a standardized electronic 
digital scale. Using the measurements, BMI (weight in 
kilograms divided by the square of  the height in meters: 
kg/m2) was then computed. 
Fasting (12 h) venous blood samples were 
collected by venipuncture into vacutainer tubes. Once 
centrifuged, the fractions were separated and frozen 
at -70 °C. Plasma glucose levels were measured by the 
glucose oxidase method with an RA-1000 auto analyzer. 
Serum insulin concentrations were measured by 
radioimmunoassay (RIA) using a commercial kit. Insulin 
resistance was estimated by using the homeostasis 
model assessment for insulin resistance (HOMA: 
fasting insulin [mU/ml] ˟ fasting glucose [mmol/l] / 
22.5). The HbA1c analysis was performed using high-
pressure liquid chromatography on a Bio-Rad Variant 
II instrument. All serum samples were stored at -80 °C 
until analysis.
The statistical analysis was performed using 
SPSS/5. Student’s unpaired t-test (parametric measures) 
and the Mann–Whitney U test (nonparametric measures) 
were used to determine statistical significance. The 
correlation analysis was performed by using Pearson’s 
correlation coefficients. To compare means across 
different glycemic categories, one-way ANOVA analysis 
was utilized. P values <0.05 were considered to be 
statistically significant.  
Results
 There was no significant difference between 
the gender ratios in the obese (Female: 48.6% / Male: 
51.4%) and in the non-obese (F: 46.7% / M: 53.3%) 
groups. The mean age in the obese group (10.09±3.09 
years) was significantly higher than that in the non-obese 
group (8.31±3.14) (P<0.05). The mean age distribution 
of  the children in the obese and non-obese groups was 
significantly different. The mean value of  the BMI was 
25.55±4.30 in the obese group and 16.63±2.3 in the 
non-obese group.
The mean value of  the HOMA-IR level in the 
obese group (2.84±1.77) was significantly higher than 
that in the non-obese group (1.5±0.95) (P<0.05). The 
percentage of  patients with HOMA-IR ≥2.5 was 44.3% 
in obese group and 16.7% in the non obese group (table 
1).
Table 1: HOMA-IR values for the obese and non-obese groups
Obese Group Non-obese Group
pmean ± SD /n-% mean ± SD /n-%
HOMA-IR 2.84 ± 1.77 1.50 ± 0.95 0.000**
HOMA-IR
<2.5 39 55.7% 50 83.3%
0.000*≥2.5 31 44.3% 10 16.7%
SD: Standard deviation; * Chi-Square Test; **Mann-Whitney U Test,
Insulin resistance was significantly higher in 
the obese group (P<0.05). There was no statistically 
significant difference between the HbA1c values of  the 
obese (5.46±0.5) and non obese groups (5.36±0.52). 
Serum fasting glucose levels were not significantly 
different in the obese (87.99±7.17) and non-obese 
groups (86.15±9.22). The serum fasting insulin level of  
the obese group (12.97±7.91) was significantly higher 
than that of  the non-obese group (6.8±3.93) (p<0.05) 
(table 2). 
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Table 2: Glucose, Insulin, and HbA1c levels of  the obese and non-obese groups
Obese Group Non-obese Group
pmean ± SD / n-% mean ± SD / n-%
HbA1c (%) 5.46 ± 0.50 5.38 ± 0.52 0.451*
Glucose (mg/dl) 87.99 ± 7.17 86.15 ± 9.22 0.205*
Insulin (mIU/ml) 12.97 ± 7.91 6.80 ± 3.93 0.000*
SD: Standard deviation; *Student t Test
There was a positive correlation between BMI 
and HOMA-IR, HbA1c, and insulin levels. There was 
no significant correlation between BMI and glucose 
levels. 
In the obese group, there was no significant 
gender difference between the children who had 
HOMA-IR <2.5 and HOMA-IR ≥2.5. In the obese 
group, the mean age distribution was significantly higher 
for children with HOMA-IR ≥2.5 than for those with 
HOMA-IR <2.5 (P<0.05).
In the obese group, the HbA1c, insulin, and 
glucose levels were significantly higher for children 
with HOMA-IR ≥2.5 (5.46±0.27) than for those with 
HOMA-IR <2.5 (P<0.05) (table 3).
Table 3: Evaluation of  BMI, HbA1c, and glucose and insulin levels among the obese group with HOMA-IR ≥2.5 
and HOMA-IR <2.5
Obese Group
HOMA-IR <2.5 HOMA-IR ≥2.5
pmean ± SD mean ± SD
HbA1c (%) 5.43 ± 0.18 5.46 ± 0.27 0.000*
Glucose (mg/dl) 86.13 ± 7.77 90.32 ± 5.64 0.016*
Insulin (mIU/ml) 7.77 ± 2.90 19.52 ± 7.34 0.000*
BMI (kg/m²) 23.45 ± 3.23 28.17 ± 4.07 0.476*
SD: standard deviation; *Mann-Whitney U Test 
In the non-obese group, the glucose and 
insulin levels were significantly higher for children with 
HOMA-IR ≥2.5 than for those with HOMA-IR <2.5 
(table 4).  
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Table 4: Evaluation of  BMI, HbA1c, and glucose and insulin levels among the non-obese group with 
HOMA-IR ≥2.5 and HOMA-IR <2.5
Non-obese Group
HOMA-IR <2.5 HOMA-IR ≥2.5
pmean ± SD mean ± SD
HbA1c (%) 5.38 ± 0.20 5.30 ± 0.36 0.606*
Glucose (mg/dl) 84.84 ± 9.16 92.70 ± 6.60 0.013*
Insulin (mIU/ml) 5.42 ± 2.49 13.70± 1.95 0.000*
BMI (kg/m²) 16.52 ± 2.15 17.18 ± 3.01 0.695*
SD: standard deviation; *Mann-Whitney U Test 
But there was no positive correlation between 
HOMA-IR and HbA1c levels in the non-obese group. 
The HOMA-IR measurements were significantly 
Table 5: Evaluation of  HOMA-IR levels between the groups with HbA1c ≤5.5 and HbA1c >5.5
HbA1c ≤ 5.5 HbA1c > 5.5
pmean ± SD mean ± SD
HOMA-IR 2.08 ± 1.56 2.71 ± 1.63 0.035*
SD: standard deviation, * Mann-Whitney U Test
Discussion
The prevalence of  obesity in children and 
adolescents has reached epidemic proportions in both 
developed and developing countries‪ (1). Insulin 
resistance in adults has been recognized for decades 
as a cardinal feature in the development of  type 2 
diabetes and has been associated with obesity, metabolic 
syndrome, hypertension, and heart disease (2, 3).  
Obesity Research Clinical Practice also clear that insulin 
resistance is significantly related to obesity and cardio 
metabolic risk in children (4, 5).  
Because an earlier onset of  obesity in children is 
responsible for lengthening the insulin-resistant status 
of  obese children, recognition of  impaired glucose 
tolerance in children is important. Previous studies 
have reported that 13-14% of  children between 6 and 
10 years old and adolescents between 12 and 19 years 
old were overweight. The epidemic percentage of  obese 
young people reached 15.5% during the years 1999-
2001(6). Subjects who had a BMI of  28 kg/m2 showed 
a marked increase in the frequency of  cardiovascular 
risk factors such as high blood pressure, dyslipidemia, 
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higher in children with HbA1c levels ≥5.5 (2.71±1.63) 
than in those with HbA1c levels <5.5 (2.08±1.56) 
(p<0.05) (table 5).
and insulin resistance (7). It has been reported that 
childhood obesity can lead to complications involving 
insulin resistance in adulthood, so it is important to 
prevent obesity in the young at-risk population (8).   
HOMA, the most widely used surrogate measure 
in children, is highly correlated with fasting insulin (r 
≥ 0.95) in children (9). Fasting glucose is maintained 
within a narrow range among  obese children and those 
with abnormal glucose tolerance (10, 11). 
In a study at the University Aichi in Japan, 
the fasting insulin levels of  10-13 year old girls were 
significantly higher (8.83±3.74 mIU/ml) than those of  
the boys (7.09±3.27 mIU/ml) (p<0.01). The HOMA-
IR levels of  Japanese girls (2.01±0.89) 10-13 years 
old were significantly higher than those of  the boys 
(1.67±0.81) (p<0.05). German girls 5-17 years old had a 
higher HOMA-IR mean value of  3.13 while boys from 
a similar cohort had a HOMA-IR level of  2.64). The 
mean HOMA-IR level of  7-10 year old Brazilian girls 
was 3.8±2.3, which was higher than that of  the boys in 
the study (2.6±1.3) (11, 12).
In their study, Hoffman et al. reported that girls 
were less sensitive to insulin, so they compensated by 
increasing insulin secretions. This decreased sensitivity 
is why girls carry a higher insulin resistance risk than 
boys (13).
In a study in Japan, although HbA1c levels and 
fasting glucose levels did not show a correlation with the 
BMI values, fasting insulin and HOMA-IR levels were 
significantly higher in overweight children. The mean 
value of  the HOMA-IR levels was 2.51±1.01 (showing 
insulin resistance) in the overweight group, and the 
percentage of  subjects with HOMA-IR levels ≥2.5 was 
46.8%. However, in the other groups, which included 
normal weight children,  the percentage was 13-20%. 
Japanese overweight children showed a tendency toward 
high insulin resistance (14).
In our study, the mean value of  the HOMA-IR 
levels was higher in the obese group than in the non-obese 
group. The percentage of  subjects with HOMA-IR ≥2.5 
was 44.3% in the obese group, while the percentage was 
only 16.7% in the non-obese group. Insulin resistance 
and fasting insulin levels were significantly higher in the 
obese group compared with the non-obese group. Our 
findings are similar to previous studies in the literature.
Valerio et al. from Italy reported that among 
3-16 year old children, age or pubertal stage and BMI 
were associated with insulin resistance (HOMA-IR). 
The positive correlation with age, with pubertal stage 
in particular, is well documented because puberty is 
associated with a transient reduction of  25-30% in insulin 
sensitivity that mainly occurs in mid-puberty. Valerio’s 
study demonstrated that the mean age of  patients with 
HOMA-IR levels ≥2.5 was higher in the obese group 
than the mean age of  patients with HOMA-IR ≤2.5 in 
the non-obese group. In the obese group, 80% of  the 
children were in the pubertal age range of  8-12 years 
old, and in the non-obese group, 56% of  the children 
were in the 8-12 year old pubertal stage (15). These 
findings are similar to those from our study, which show 
that HOMA-IR levels correlate with age, particularly 
the pubertal stage. In our study, the percentage of  8-12 
years old children was 14.3% in the obese group and 
51.6% in the non-obese group. The HOMA-IR levels 
of  the obese group were significantly higher than those 
of  the non-obese group. Most of  the children in the 
obese group who had a high HOMA-IR level were in 
the pubertal stage. During puberty, there is a 25-30% 
decline in insulin sensitivity, which is recovered when 
pubertal development is complete (16).
Although HbA1c is used to diagnose type 
II diabetes, it is unknown whether elevated HbA1c 
levels within a non-diabetic range can reliably reflect 
insulin resistance or impairment of  insulin secretion 
in individuals not being treated for diabetes. A study 
performed in Toranoman Hospital in Japan, published 
in Diabetic Medicine in 2012, demonstrated that 
elevated HbA1c levels within a non-diabetic range were 
associated with impaired insulin secretion, even without 
escalating insulin resistance. Elevated HbA1c levels 
≥5.9% were associated with substantial reductions 
in insulin secretion and insulin sensitivity and in 
β-cell dysfunction in Japanese individuals. Moreover, 
impaired early phase insulin secretion and relative β-cell 
dysfunction were suggested to already exist among 
individuals with high normal HbA1c (5.4-5.8%) levels 
even when insulin resistance was not increased (17).  
In the obese group in our study, children with 
HOMA-IR levels ≥2.5 showed significantly higher 
HbA1c values than those with HOMA-IR levels 
<2. However, in the non obese group, there was no 
significant difference in the HbA1c levels of  those 
with HOMA-IR ≥2.5 and those with HOMA-IR <2.5. 
These results demonstrate that insulin resistance related 
to obesity plays a major role in the development of  
diabetes mellitus.
HbA1c has the potential to reflect the history 
of  mean insulin sensitivity over the preceding weeks or 
months, and it serves as a marker of  insulin sensitivity 
in children who have a normal glucose tolerance (18).  
HbA1c levels can be used as a diagnostic tool for the 
early detection of  insulin resistance.
Since we found a positive correlation between 
HbA1c and HOMA-IR levels only in the obese group, 
we suggest using HbA1c levels as a simple and cheaper 
marker only in obese children with relatively high 
insulin sensitivity. Insulin resistance can be evaluated 
by screening HOMA-IR levels in obese children. But 
in higher HbA1c levels within the ranges of  5.5-6 % , 
we determined a correlation between HOMA-IR and 
HbA1c levels. We suggest firstly screening HbA1c 
levels, a cheaper and easy method ( no need to fasting) 
in order to evaluate insulin sensitivity in obese children. 
Comprehensive studies that include more subjects can 
be used to confirm this assertion in the future.
Insulin resistance, which is the component of  
metabolic syndrome, is more commonly seen in obese 
children, compared to non-obese ones. It is important 
to identify insulin resistance at an early stage. HbA1c 
screening can be used as a cheaper and simple ( no 
need to fasting ) method in order to evaluate insulin 
resistance in obese children.
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